NeuroPace (NPCE) Current Deferred Revenue (2020 - 2026)

NeuroPace's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $100000.0 for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 85.71% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (down 85.71% YoY), while the FY2025 annual figure was $100000.0, down 83.33% from the prior year.
• Current Deferred Revenue was $100000.0 for Q1 2026 at NeuroPace, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q4 2023 to a low of $100000.0 in Q4 2025.
• Historically, Current Deferred Revenue has averaged $625500.0 across 4 years, with a median of $698000.0 in 2024.
• The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue declined 13.0% in 2025, then sank 85.71% in 2026.
• A 4-year view of Current Deferred Revenue shows it stood at $1.1 million in 2023, then sank by 44.95% to $600000.0 in 2024, then sank by 83.33% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
• The last three Current Deferred Revenue figures came in at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $600000.0 (Q3 2025), per Business Quant data.